ArticleFrontiers in pharmacology2020

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men.

Hong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.